Serological diagnosis of Epstein-Barr virus infection: Problems and solutions

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 1, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

2000

HTML

21828

Tables (1-6)

550

Sum=24378

Feb 12, 2012 (publication date) through Feb 21, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Virol . Feb 12, 2012; 1(1): 31-43
Published online Feb 12, 2012. doi: 10.5501/wjv.v1.i1.31

Table 1 Types of latency in Epstein-Barr virus-associated diseases

Type 0 latency (EBERs, BARTs)	AIDS-related plasmablastic lymphoma
Type I latency (EBNA1, LMP2, EBERs, BARTs) (BamHI A rightward fragments)	Burkitt’s lymphoma
Type II latency (EBNA1, LMP1, LMP2, EBERs, BARTs)	Hodgkin’s lymphoma, AIDS-related Burkitt’s lymphoma or primary effusion lymphoma
	Peripheral T cell lymphoma
	NK/T cell lymphoma, nasal type
	Nasopharyngeal carcinoma (plus BARF1)
	Gastric adenocarcinoma (plus BARF1)
Type III latency (EBNA1, -2, -3A, -3B, -3C; LMP1, LMP2, EBERs, BARTs)	Post-transplant lymphoproliferative disorder
	AIDS-related immunoblastic or brain lymphoma
	Infectious mononucleosis
	Chronic active EBV infection
	Lymphoblastoid cell lines in vitro
	X-linked lymphoproliferative disease

Citation: De Paschale M, Clerici P. Serological diagnosis of Epstein-Barr virus infection: Problems and solutions. World J Virol 2012; 1(1): 31-43
URL: https://www.wjgnet.com/2220-3249/full/v1/i1/31.htm
DOI: https://dx.doi.org/10.5501/wjv.v1.i1.31